Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Reck

Showing results (61-70 of 437) with videos related to

Pageof 44
Sort By:
Lung Cancer (Amsterdam, Netherlands)|July 13, 2010
Characteristics, treatment patterns and outcomes of patients with small cell lung cancer--a retrospective single institution analysisAndreas Hermes, Benjamin Waschki, Ulrich Gatzemeier, et al.
Respiratory Medicine|August 20, 2010
Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer - a retrospective single institution analysisAndreas Hermes, Ulrich Gatzemeier, Benjamin Waschki, et al.
Lung Cancer (Amsterdam, Netherlands)|November 17, 2009
Targeted therapies for non-small cell lung cancerWolfram C M Dempke, Tamas Suto, Martin Reck
Expert Review of Anticancer Therapy|December 29, 2018
Prospects of targeted and immune therapies in SCLCLizza E L Hendriks, Jessica Menis, Martin Reck
JAMA Oncology|November 4, 2021
Analysis of Outcomes With Addition of Immunotherapy to Chemoradiation Therapy for Non-Small Cell Lung Cancer-ReplySalma K Jabbour, Steven M Keller, Martin Reck
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 21, 2022
Chemotherapy + PD-1/PD-L1 Blockade Should Not Be the Preferred Option in the Neoadjuvant Therapy of NSCLCLizza E L Hendriks, Jordi Remon, Martin Reck
Lung Cancer (Amsterdam, Netherlands)|September 17, 2019
Immune checkpoint blockade in small cell lung cancerRebecca Y Tay, David Heigener, Martin Reck, et al.
Onkologie|June 27, 2008
[Therapy in elderly patients]Hendrik C Dienemann, Wilfried Eberhardt, Rainer Fietkau, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 3, 2006
[EGFR/HER1 inhibition: an example of new targeted therapies in non-small cell lung cancer]Martin Reck, Anne L Kranich, Alma Katharina Steinbach, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 2019
Perceived relatedness, death acceptance, and demoralization in patients with cancerRebecca Philipp, Anja Mehnert, Volkmar Müller, et al.
Pageof 44

Showing results (61-70 of 437) with videos related to

Sort By:
Pageof 44
Lung Cancer (Amsterdam, Netherlands)|July 13, 2010
Characteristics, treatment patterns and outcomes of patients with small cell lung cancer--a retrospective single institution analysisAndreas Hermes, Benjamin Waschki, Ulrich Gatzemeier, et al.
Respiratory Medicine|August 20, 2010
Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer - a retrospective single institution analysisAndreas Hermes, Ulrich Gatzemeier, Benjamin Waschki, et al.
Lung Cancer (Amsterdam, Netherlands)|November 17, 2009
Targeted therapies for non-small cell lung cancerWolfram C M Dempke, Tamas Suto, Martin Reck
Expert Review of Anticancer Therapy|December 29, 2018
Prospects of targeted and immune therapies in SCLCLizza E L Hendriks, Jessica Menis, Martin Reck
JAMA Oncology|November 4, 2021
Analysis of Outcomes With Addition of Immunotherapy to Chemoradiation Therapy for Non-Small Cell Lung Cancer-ReplySalma K Jabbour, Steven M Keller, Martin Reck
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 21, 2022
Chemotherapy + PD-1/PD-L1 Blockade Should Not Be the Preferred Option in the Neoadjuvant Therapy of NSCLCLizza E L Hendriks, Jordi Remon, Martin Reck
Lung Cancer (Amsterdam, Netherlands)|September 17, 2019
Immune checkpoint blockade in small cell lung cancerRebecca Y Tay, David Heigener, Martin Reck, et al.
Onkologie|June 27, 2008
[Therapy in elderly patients]Hendrik C Dienemann, Wilfried Eberhardt, Rainer Fietkau, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 3, 2006
[EGFR/HER1 inhibition: an example of new targeted therapies in non-small cell lung cancer]Martin Reck, Anne L Kranich, Alma Katharina Steinbach, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 2019
Perceived relatedness, death acceptance, and demoralization in patients with cancerRebecca Philipp, Anja Mehnert, Volkmar Müller, et al.
Pageof 44